Mogamulizumab Antibody
Mogamulizumab (KW-0761) is a monoclonal antibody targeting CC chemokine receptor 4 (CCR4) . It exerts anti-cancer effects primarily through antibody-dependent cellular cytotoxicity (ADCC) and is utilized in research for adult T-cell leukemia/lymphoma (ATLL) and cutaneous T-cell lymphoma (CTCL), including in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
KW 0761, KW0761, KW-0761, Mogamulizumab, CXCR4
Target
CCR, CXCR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery
Concentration
3.06 mg/mL
Purity
97.50% (May vary between batches)
Molecular Weight
146.43 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Bovine C-C Motif Chemokine Ligand 19 (CCL19) ELISA Kit-Sandwich
Bovine C-C Motif Chemokine Ligand 19 (CCL19) ELISA Kit-Sandwich
Jsrp1 sgRNA CRISPR Lentivector (Mouse) (Target 3)
5- (Methylamino) -3-morpholin-4-ylisothiazole-4-carbonitrile
5- (Methylamino) -3-morpholin-4-ylisothiazole-4-carbonitrile